Plant Virome Diagnostics Global Market Report 2026

Plant virome diagnostics refers to the techniques and technologies used to detect and identify viruses present in plants. It incorporates molecular and genomic approaches to analyze viral populations that impact plant health and agricultural productivity. Plant virome diagnostics aids in early disease identification and the implementation of effective crop management strategies.

The primary product types of plant virome diagnostics include kits and reagents, instruments, and software and services. Kits and reagents refer to ready-to-use diagnostic consumables developed for identifying plant viruses using molecular and biochemical methods. The technologies include polymerase chain reaction-based diagnostics, next-generation sequencing, serological tests, microarray-based diagnostics, and other technologies. The key applications include research, clinical diagnostics, agricultural biosecurity, and other applications, while the end-use includes research institutes, diagnostic laboratories, agricultural companies, and other end-users.

Tariffs are influencing the plant virome diagnostics market by increasing the cost of imported sequencing instruments, molecular reagents, and advanced diagnostic kits required for plant viral genome analysis. This is slowing the adoption of high-end technologies, particularly in import-dependent regions such as Asia-Pacific and Latin America, where agricultural biosecurity relies heavily on international suppliers. Segments such as next-generation sequencing instruments and molecular reagent kits are most impacted due to strong dependence on specialized components. However, tariffs are also encouraging local manufacturing of diagnostic kits, strengthening regional biotechnology ecosystems, and promoting investment in domestic sequencing infrastructure, which is improving long-term accessibility and resilience.

The plant virome diagnostics market research report is one of a series of new reports from The Business Research Company that provides plant virome diagnostics market statistics, including plant virome diagnostics industry global market size, regional shares, competitors with a plant virome diagnostics market share, detailed plant virome diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the plant virome diagnostics industry. This plant virome diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plant virome diagnostics market size has grown strongly in recent years. It will grow from $1.03 billion in 2025 to $1.12 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising incidence of plant viral outbreaks in major crops, increasing reliance on molecular diagnostics in agriculture, growing awareness of crop yield losses due to viruses, expansion of agricultural biotechnology research programs, adoption of basic pcr-based plant disease testing methods.

The plant virome diagnostics market size is expected to see strong growth in the next few years. It will grow to $1.61 billion by 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing adoption of next generation sequencing technologies, rising demand for precision agriculture and early disease detection, growth in digital agriculture and data-driven farming, expansion of portable and field-based diagnostic solutions, increasing investment in plant health biosecurity and virome research. Major trends in the forecast period include metagenomic sequencing-based plant virome profiling for early virus detection, high-throughput next generation sequencing for plant viral diversity mapping, cloud-based virome data analytics platforms for real-time disease surveillance, portable molecular diagnostic kits for rapid field virus detection, advanced bioinformatics pipelines for plant virus identification and classification.

The rising incidence of plant viral diseases is expected to propel the growth of the plant virome diagnostics market going forward. Plant viral diseases are infections in plants caused by viruses that interfere with normal growth, decrease yield, and can spread rapidly through vectors, seeds, or mechanical transmission. The incidence of plant viral diseases is increasing due to the expansion of global trade and movement of plant materials, which facilitates the transmission of viruses across regions and crops. The increasing incidence of plant viral diseases is boosting demand for plant virome diagnostics, as growers and laboratories require accurate and timely detection tools to control infections and safeguard crop yields. For instance, in July 2025, according to the Department of Primary Industries and Regions (PIRSA), an Australia-based government department, turnip yellows virus (TuYV) impacts canola and major pulse crops in Australia, causing yield losses ranging from 10-80%, with earlier infections resulting in greater losses, highlighting the growing economic risk associated with plant viral diseases. Therefore, the rising incidence of plant viral diseases is driving the growth of the plant virome diagnostics market.

Leading companies operating in the plant virome diagnostics market are focusing on developing advanced solutions, such as next-generation sequencing (NGS), to support faster, field-deployable, and highly sensitive detection of plant viruses for enhanced crop health management. Next-generation sequencing (NGS) for comprehensive virome analysis refers to advanced molecular technologies that enable simultaneous detection and characterization of multiple plant viruses from a single sample, delivering high sensitivity, specificity, and broad-spectrum pathogen identification. For instance, in May 2025, Agdia Inc. launched the Rapid Molecular Test Kit for Begomovirus spp. on its AmplifyRP XRT platform. The test kit enables rapid on-site detection of Begomovirus species in less than 30 minutes using recombinase polymerase amplification (RPA) technology without requiring nucleic acid purification. It delivers high diagnostic accuracy with 97.7% sensitivity and 100% specificity, supporting both laboratory and field testing across multiple crop species.

In September 2024, Eurofins Agroscience Services acquired Verdelab Bioscience for an undisclosed amount. With this acquisition, Eurofins aims to expand its plant pathology and plant virus diagnostic capabilities by strengthening laboratory testing services for seed companies and plant breeders while enhancing its integrated plant health diagnostic solutions. Verdelab Bioscience is an Italy-based plant pathology diagnostic laboratory specializing in the detection of plant viruses, fungi, bacteria, and phytoplasmas.

Major companies operating in the plant virome diagnostics market are BASF SE, Thermo Fisher Scientific Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., Qiagen N. V., Promega Corporation, AsureQuality Ltd., Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ), CD Genomics Inc., Creative Diagnostics Inc., PathogenDx Inc., Agdia Inc., Abingdon Health Ltd., Norgen Biotek Corp., Lifeasible Inc., LOEWE Biochemica GmbH, Qualiplante SAS, Phytodiagnostics Inc., OptiGene Limited, Plant Print Diagnostics S. L., IGATech SA

North America was the largest region in the plant virome diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plant virome diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the plant virome diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The plant virome diagnostics market consists of revenues earned by entities by providing services such as plant virus detection services, plant virus identification services, viral genome sequencing services, pathogen screening services, disease surveillance services, diagnostic consulting services, customized assay development services and sample testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The plant virome diagnostics market also includes sales of multiplex PCR panels, sample extraction kits, portable field diagnostic instruments, and thermocyclers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plant Virome Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses plant virome diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plant virome diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The plant virome diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Kits And Reagents; Instruments; Software And Services
• 2) By Technology: Polymerase Chain Reaction Based Diagnostics; Next Generation Sequencing; Serological Tests; Microarray Based Diagnostics; Other Technologies
• 3) By Application: Research; Clinical Diagnostics; Agricultural Biosecurity; Other Applications
• 4) By End-User: Research Institutes; Diagnostic Laboratories; Agricultural Companies; Other End-Users
• Subsegments:
• 1) By Kits And Reagents: Enzyme Linked Kits; Lateral Flow Kits; Nucleic Acid Extraction Kits; Polymerase Chain Reaction Reagents; Other Kits And Reagents
• 2) By Instruments: Real Time Polymerase Chain Reaction Machines; Next Generation Sequencers; Microarray Scanners; Biosensors; Other Instruments
• 3) By Software And Services: Data Analysis Software; Cloud Based Diagnostic Platforms; Consulting Services; Laboratory Testing Services; Other Software And Services
• Companies Mentioned: BASF SE; Thermo Fisher Scientific Inc.; Eurofins Scientific SE; Bio-Rad Laboratories Inc.; Qiagen N.V.; Promega Corporation; AsureQuality Ltd.; Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ); CD Genomics Inc.; Creative Diagnostics Inc.; PathogenDx Inc.; Agdia Inc.; Abingdon Health Ltd.; Norgen Biotek Corp.; Lifeasible Inc.; LOEWE Biochemica GmbH; Qualiplante SAS; Phytodiagnostics Inc.; OptiGene Limited; Plant Print Diagnostics S.L.; IGATech SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.